<p><b>A)</b> Top, vaccination schedule. Bottom, tumor survival data (n = 10). Black star corresponds to day 0, when tumor cells were inoculated. Black arrows indicate the vaccination days (5 and 12). Symbols are as indicated in the square. <b>B)</b> Evolution of tumor size. Values shown are from individual mice in each group, as indicated in each panel. Animals were sacrificed when tumors reached 1 cm<sup>3</sup> (blue line). A representative tumor-bearing control mouse (necropsy) is shown in the photograph.</p
<p>Tumors are outlined with dotted lines to aid in visualization. Two top rows show tumors growing f...
Analysis of anti-tumor immunity for therapeutic effect. 1 weeks after immunization by dissolving-mic...
<p><b>(A</b>) Top and profile view pictures of a mouse with multiple UVB-induced skin cancers for ph...
<p><b>A)</b> Top, vaccination schedule. Bottom; tumor survival data (n = 9). Black star corresponds ...
<p>Therapeutic immunization: mice were challenged with 2×10<sup>5</sup> TC-1 cells on day 0 and vacc...
<p>(A) Schematic diagram depicting the regimen. On Day 1, TC-1 cells were injected subcutaneously. F...
<p>In cell depletion experiments, control isoptypes (Ig) similar to the antibody used to deplete T c...
<p><b>A</b>: Schematic diagram of the therapeutic vaccination Two groups of BALB/c mice (n = 7) were...
<p>A. Tumor weight changes at the end of experiments after combination test, combination control or ...
<p><b>A</b>. Individual tumor volume was plotted over time (days) for vehicle and TM5441 (20 mg/kg/d...
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
<p>(A) Vaccination schedule. (B) Mice (n = 5) were immunized with various DNA vaccines and challenge...
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
<p>Tumors are outlined with dotted lines to aid in visualization. Two top rows show tumors growing f...
Analysis of anti-tumor immunity for therapeutic effect. 1 weeks after immunization by dissolving-mic...
<p><b>(A</b>) Top and profile view pictures of a mouse with multiple UVB-induced skin cancers for ph...
<p><b>A)</b> Top, vaccination schedule. Bottom; tumor survival data (n = 9). Black star corresponds ...
<p>Therapeutic immunization: mice were challenged with 2×10<sup>5</sup> TC-1 cells on day 0 and vacc...
<p>(A) Schematic diagram depicting the regimen. On Day 1, TC-1 cells were injected subcutaneously. F...
<p>In cell depletion experiments, control isoptypes (Ig) similar to the antibody used to deplete T c...
<p><b>A</b>: Schematic diagram of the therapeutic vaccination Two groups of BALB/c mice (n = 7) were...
<p>A. Tumor weight changes at the end of experiments after combination test, combination control or ...
<p><b>A</b>. Individual tumor volume was plotted over time (days) for vehicle and TM5441 (20 mg/kg/d...
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
<p>(A) Vaccination schedule. (B) Mice (n = 5) were immunized with various DNA vaccines and challenge...
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
<p>Tumors are outlined with dotted lines to aid in visualization. Two top rows show tumors growing f...
Analysis of anti-tumor immunity for therapeutic effect. 1 weeks after immunization by dissolving-mic...
<p><b>(A</b>) Top and profile view pictures of a mouse with multiple UVB-induced skin cancers for ph...